People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

4 May 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

von Planta, Andreas 

Dr. Andreas von Planta, Ph.D., has been Member of the Board of Directors at Novartis AG since February 28, 2006. He qualifies as an independent Non-Executive Director of the Company. He is Chairman of the Risk Committee, Member of the Audit and Compliance Committee, and the Corporate Governance and Nomination Committee at the Company. He passed his bar examinations in Basel in 1982. Since 1983, he has been working for the law firm Lenz & Staehelin in Geneva, where he became a partner in 1988. His areas of specialization include corporate law, corporate finance, company reorganizations, and mergers and acquisitions. Mr. von Planta is Chairman of the Schweizerische National-Versicherungs-Gesellschaft AG and a Board Member of Holcim Ltd., both in Switzerland. He is also a Board Member of various Swiss subsidiaries of foreign companies and other nonlisted Swiss companies. He is Member of the Board of Editors of the Swiss Review of Business Law and former Chairman of the Geneva Association of Business Law. Mr. von Planta is Chairman of the regulatory board of the SIX Swiss Exchange AG. Mr. von Planta holds Lizentiat des Rechts (lic. iur., LLB) and Doctorote in Philosophy (Ph.D.) degrees from Universitaet Basel, Switzerland, and an Master of Laws (LL.M.) from Columbia University School of Law, New York, United States.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
560,056 -- 29,023 589,079

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt


Joseph Jimenez


Ulrich Lehner


Harry Kirsch


Peter Kornicker


Felix Ehrat

As Of  30 Dec 2013
Search Stocks